TY - JOUR AU - Bono, J. S. AU - Oudard, S. AU - Ozguroglu, M. AU - Hansen, S. AU - Machiels, J. P. AU - Kocak, I. PY - 2010 DA - 2010// TI - Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial JO - Lancet. VL - 376 UR - https://doi.org/10.1016/S0140-6736(10)61389-X DO - 10.1016/S0140-6736(10)61389-X ID - Bono2010 ER - TY - JOUR AU - Hou, H. W. AU - Warkiani, M. E. AU - Khoo, B. L. AU - Li, Z. R. AU - Soo, R. A. AU - Tan, D. S. PY - 2013 DA - 2013// TI - Isolation and retrieval of circulating tumor cells using centrifugal forces JO - Sci Rep VL - 3 UR - https://doi.org/10.1038/srep01259 DO - 10.1038/srep01259 ID - Hou2013 ER - TY - JOUR AU - Kosaka, T. AU - Shinojima, T. AU - Morita, S. AU - Oya, M. PY - 2018 DA - 2018// TI - Prognostic significance of grade 3/4 neutropenia in Japanese prostate cancer patients treated with cabazitaxel JO - Cancer Sci VL - 109 UR - https://doi.org/10.1111/cas.13556 DO - 10.1111/cas.13556 ID - Kosaka2018 ER - TY - JOUR AU - Armstrong, A. J. AU - Marengo, M. S. AU - Oltean, S. AU - Kemeny, G. AU - Bitting, R. L. AU - Turnbull, J. D. PY - 2011 DA - 2011// TI - Circulating tumor cells from patients with advanced prostate and breast cancer display both epithelial and mesenchymal markers JO - Mol Cancer Res VL - 9 UR - https://doi.org/10.1158/1541-7786.MCR-10-0490 DO - 10.1158/1541-7786.MCR-10-0490 ID - Armstrong2011 ER - TY - JOUR AU - Beltran, H. AU - Jendrisak, A. AU - Landers, M. AU - Mosquera, J. M. AU - Kossai, M. AU - Louw, J. PY - 2016 DA - 2016// TI - The initial detection and partial characterization of circulating tumor cells in neuroendocrine prostate Cancer JO - Clin Cancer Res VL - 22 UR - https://doi.org/10.1158/1078-0432.CCR-15-0137 DO - 10.1158/1078-0432.CCR-15-0137 ID - Beltran2016 ER - TY - JOUR AU - Miyamoto, D. T. AU - Sequist, L. V. AU - Lee, R. J. PY - 2014 DA - 2014// TI - Circulating tumour cells-monitoring treatment response in prostate cancer JO - Nat Rev Clin Oncol VL - 11 UR - https://doi.org/10.1038/nrclinonc.2014.82 DO - 10.1038/nrclinonc.2014.82 ID - Miyamoto2014 ER -